These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 28752332)
1. Adverse bone effects of medications used to treat non-skeletal disorders. Watts NB Osteoporos Int; 2017 Oct; 28(10):2741-2746. PubMed ID: 28752332 [TBL] [Abstract][Full Text] [Related]
2. [Fracture risk associated with drugs other than glucocorticoids]. Okazaki R Clin Calcium; 2014 Mar; 24(3):357-65. PubMed ID: 24576932 [TBL] [Abstract][Full Text] [Related]
3. Update on medications with adverse skeletal effects. Davidge Pitts CJ; Kearns AE Mayo Clin Proc; 2011 Apr; 86(4):338-43; quiz 343. PubMed ID: 21389249 [TBL] [Abstract][Full Text] [Related]
4. Drug-induced bone loss: a major safety concern in Europe. Nguyen KD; Bagheri B; Bagheri H Expert Opin Drug Saf; 2018 Oct; 17(10):1005-1014. PubMed ID: 30222369 [TBL] [Abstract][Full Text] [Related]
9. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs]. Suzuki H Clin Calcium; 2013 Sep; 23(9):1307-12. PubMed ID: 23999367 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid-Induced Bone Loss: Dietary Supplementation Recommendations to Reduce the Risk for Osteoporosis and Osteoporotic Fractures. Chen KL; Gannon NP; Tofte JN; Shields BE Cutis; 2022 Oct; 110(4):201-206. PubMed ID: 36446101 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced osteoporosis: Insights for the clinician. Hayat S; Magrey MN Cleve Clin J Med; 2020 Jun; 87(7):417-426. PubMed ID: 32605977 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced osteoporosis: mechanisms and clinical implications. Mazziotti G; Canalis E; Giustina A Am J Med; 2010 Oct; 123(10):877-84. PubMed ID: 20920685 [TBL] [Abstract][Full Text] [Related]
13. Drugs that may harm bone: Mitigating the risk. Hant FN; Bolster MB Cleve Clin J Med; 2016 Apr; 83(4):281-8. PubMed ID: 27055202 [TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Wu Q; Bencaz AF; Hentz JG; Crowell MD Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950 [TBL] [Abstract][Full Text] [Related]
15. Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome. Bruyère O; Reginster JY Endocrine; 2015 Feb; 48(1):65-8. PubMed ID: 25091520 [TBL] [Abstract][Full Text] [Related]